Fig. 6From: An integrated approach of bioinformatic prediction and in vitro analysis identified that miR-34a targets MET and AXL in triple-negative breast cancerComparison of miR-34a, MET, and AXL expression before and after miR-34a induction in the cell lines. Results showed that, after miR-34a induction, MET and AXL expression decreased in MDA-MB-231 cells. In SK-BR-3 cells, MET expression decreased, but AXL expression increasedBack to article page